Perfluorodecalin is a perfluorocarbon liquid used intraoperatively in
retinal detachment repair. It is usually removed at the end of the pro
cedure; however, residual amounts may be retained when poor corneal cl
arity or intraocular hemorrhage obscures the view. No clinical reports
exist on the consequences of retained perfluorodecalin in the anterio
r segment. We report five cases in which perfluorodecalin was in prolo
nged contact with the cornea. The period of time for corneal pathology
to occur and the role perfluorodecalin played in the etiology of such
changes is discussed. A total of 348 patients with retinal detachment
s in one retinal practice underwent repair using pars plana vitrectomy
combined with intraoperative perfluorodecalin between January 1992 an
d May 1994. Postoperatively, residual perfluorodecalin was observed in
the anterior chamber in contact with the corneal endothelium in five
patients. The patients were followed clinically for a period of up to
18 months. Four of five patients developed corneal changes from prolon
ged contact with perfluorodecalin. Corneal edema developed in the area
of perfluorodecalin-endothelial contact in three of five eyes. The pe
riod of perfluorodecalin-endothelial contact before corneal decompensa
tion occurred ranged from 4 to 13 weeks. Two eyes required penetrating
keratoplasties for progressive corneal edema. Corneal edema was rever
sed in one eye after removal of perfluorodecalin from the anterior cha
mber via multiple paracentesis. One of the remaining eyes developed de
ep corneal vascularization without edema in the area of perfluorodecal
in contact after 12 months. These observations suggest that corneal to
xicity may be induced by intraocular perfluorodecalin if it is allowed
direct contact with the corneal endothelium for periods as short as 1
month. Some of these changes may be reversible if perfluorodecalin is
aspirated from the anterior chamber. Further investigations are requi
red to examine perfluorodecalin-induced corneal toxicity.